Company intelligence / Profile preview
Battery Bio Australia
Brisbane, Queensland, Australiabatterybio.com ↗
- Ownership
- Private
- Development stage
- Other
01
Overview
Battery Bio is an Australian biotechnology company pioneering the field of immunometabolism to develop novel therapies for cancer and autoimmune diseases. The company's platform focuses on recharging the immune system by modulating the metabolic pathways that govern T cell function, fitness, and longevity. By targeting metabolic checkpoints, Battery Bio aims to overcome the immunosuppressive environments of tumors and enhance the efficacy of existing immunotherapies. Founded by world-leading experts in immunology and supported by major venture capital, the company is currently advancing a pipeline of small molecule modulators through pre-clinical development.
- Therapeutic areas
- OncologyImmunology
- Modalities
- Small molecule
- Industry
- Biotech
02
Drug pipeline
1 assetBeyond the preview
Go deeper on Battery Bio Australia.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Battery Bio Australia.